Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

Safety and Efficacy Extension Study of Daclizumab High Yield Process (DAC HYP) in Participants With Multiple Sclerosis Who Have Completed Study 205MS201 (NCT00390221) to Treat Relapsing-Remitting Multiple Sclerosis

Biogen · 2009
ClinicalTrials.gov · Datasets · License: Public Domain · 2009
Open Source ↗
msmultiple-sclerosis
relapsing-remitting multiple sclerosis, ms, multiple sclerosis, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 894954
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.